<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26982788</article-id>
      <article-id pub-id-type="pmc">4782656</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20163922</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Myxofibrosarcoma - Case report<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>de Castro</surname>
            <given-names>Breno Augusto Campos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piancastelli</surname>
            <given-names>Andr&#xE9; Costa Cruz</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meyer</surname>
            <given-names>Renata Leal Bregunci</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Piancastelli</surname>
            <given-names>Patricia Mourthe</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ribeiro</surname>
            <given-names>Carlos Alberto</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miranda</surname>
            <given-names>Rubem Mateus Campos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Hospital da Pol&#xED;cia Militar de Minas Gerais - Belo
Horizonte (MG), Brazil.</aff>
      <aff id="aff2"><label>2</label>Hospital Belo Horizonte &#x2013; Belo Horizonte (MG),
Brazil.</aff>
      <author-notes>
        <corresp id="c1">Mailing address: Breno Augusto Campos de Castro, Avenida do
Contorno 2787, Santa Efg&#xEA;nia,30110-013, Belo Horizonte, MG. E-mail:
<email>dermatobreno@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Feb</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>1</issue>
      <fpage>97</fpage>
      <lpage>99</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>10</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Myxofibrosarcoma is recognized as a malignant neoplasm of fibroblastic origin
with increased prevalence in the elderly, presenting as nodules or tumors that
may extend to the dermis and skeletal muscle, preferably in the lower limbs.
Histologically it is characterized by a proliferation of spindle cells in a
myxoid stroma. Myxofibrosarcoma has a high potential for local recurrence and
metastasis, mainly when it presents a high or intermediate histological grade.
We report the case of an eighty-four year old patient with a difficult diagnosis
of a highly aggressive tumor.</p>
      </abstract>
      <kwd-group>
        <kwd>Aged</kwd>
        <kwd>Myxosarcoma</kwd>
        <kwd>Neoplasm metastasis</kwd>
        <kwd>Neoplasm recurrence, local</kwd>
        <kwd>Skin neoplasms</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Myxofibrosarcoma, previously known as myxoid malignant fibrous histiocytoma, is
considered one of the most common fibroblastic sarcomas of the elderly,
predominantly affecting patients between sixty and eighty years of age.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup></p>
      <p>We report the case of an intermediate grade myxofibrosarcoma surgically resected, but
with later recurrence and metastasis to local lymph nodes.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>An 84-year-old white man presented to our division with a three month-history of an
erythematous, painful, rapidly growing tumor in the right lower limb.</p>
      <p>Dermatological examination revealed a 3.2 cm x 2.8 cm hyperkeratotic ulcerated tumor
in the posterolateral view of the right lower limb (<xref ref-type="fig" rid="f1">Figure 1</xref>). A skin biopsy was performed and the histopathology showed
proliferation of atypical spindle cells with irregular and hyperchromatic nuclei
arranged in bundles located in the papillary and reticular dermis. The
immunohistochemistry showed negative S-100, cytokeratins, ERG, p-63 and desmin
markers. Only CD34 was positive. Based on the immunohistochemistry and on the
undifferentiated histopathological pattern, the lesion was classified as an
undifferentiated pleomorphic sarcoma.</p>
      <p>
<fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Hyperkeratotic erythematous tumor with areas of ulceration in right lower
limb</p></caption><graphic xlink:href="abd-91-01-0097-g01"/></fig>
</p>
      <p>The patient was referred to the oncologist for tumor staging. Imaging tests showed
that the tumor was located above the muscle fascia; no lymph node or distant
metastasis were detected (<xref ref-type="fig" rid="f2">Figure 2</xref>). The
surgical resection was performed with a 2 cm margin and the histopathology showed
proliferation of ovoid or spindle cells arranged in bundles, with irregular,
hyperchromatic nuclei and mitotic figures, combined with myxoid stroma (<xref ref-type="fig" rid="f3">Figure 3</xref>). The presence of elongated,
curvilinear, thin-walled blood vessels was also noticed (<xref ref-type="fig" rid="f4">Figure 4</xref>). It was then reclassified as myxofibrosarcoma.</p>
      <p>The initially proposed treatment was radiotherapy. However, two months later the
patient presented local recurrence of the tumor and a right inguinal nodal
metastasis. The treatment was then changed to palliative chemotherapy with
doxorubicin.</p>
      <p>
<fig id="f2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Magnetic resonance imaging of the ankle showing expansive lesion with
defined boundaries centered in the subcutaneous plane</p></caption><graphic xlink:href="abd-91-01-0097-g02"/></fig>
</p>
      <p>
<fig id="f3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Intermediate grade myxofibrosarcoma. (A) Transition between myxoid area
and cellular area. (HE, 100X). (B) Atypical cells with scant cytoplasm
(HE, 400X).</p></caption><graphic xlink:href="abd-91-01-0097-g03"/></fig>
</p>
      <p>
<fig id="f4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Myxofibrosarcoma revealing elongated, curvilinear, thin-walled blood
vessel (HE, 400x)</p></caption><graphic xlink:href="abd-91-01-0097-g04"/></fig>
</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Myxofibrosarcoma is considered the most common malignant mesenchymal neoplasm in
elderly patients, with slight male predominance. It usually presents as painless,
slow growing, skin colored or erythematous nodules or tumors. Most lesions are
located in the lower limbs and rarely on the trunk, head and neck.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> About two-thirds of the cases
develop in the dermal and subcutaneous tissues, and one third in the fascia and
skeletal muscle.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup></p>
      <p>The diagnosis of myxofibrosarcoma is hystopathological and tumors are classified as
low, intermediate and high grade.<sup><xref rid="r2" ref-type="bibr">2</xref></sup>
The first is characterized by hypocellularity, cells with hyperchromatic and
pleomorphic nuclei associated with extensive myxoid areas. Intermediate grade tumors
are more cellular with frequent nuclear atypia. Finally, high-grade tumors are
densely cellular, pleomorphic, with numerous mitotic figures, areas of hemorrhage
and necrosis. Few areas of myxoid stroma are found with a predominantly solid
component. A characteristic histological finding is the presence of elongated,
curvilinear, thin-walled blood vessels.</p>
      <p>It is important to note that skin biopsy, when taken superficially, may show
misleading features, since the shallow portions of the tumor show benign
characteristics, whereas deeper samples show histomorphological features of
malignancy.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> Therefore
superficial biopsies may underclassify a high degree tumor or even classify it as a
benign neoplasm. This peculiar characteristic makes it very important to represent
the lesion adequately for histopathological examination.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup></p>
      <p>Due to the low specificity of immunohistochemistry in myxofibrosarcoma, the results
should always be interpreted with caution. The neoplastic cells are often positive
for vimentin and CD34, and rarely positive for smooth muscle actin. Desmin,
cytokeratins, S100 and HMB-45; CD68 are usually negative.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup></p>
      <p>Therapy consists of surgical resection with a safety margin of at least 2
cm.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> High local recurrence
rate (50-60%), regardless of the grade, results in the indication of adjuvant
radiotherapy.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> Metastasis
occur in 20-35% of high and intermediate grade tumors, especially in bones and
lungs.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref></sup> As it is a
rare disease, more studies are needed to establish the benefit of chemotherapy.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interest: None.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at the Hospital da Pol&#xED;cia Militar de Minas Gerais - Belo
Horizonte (MG), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Mentzel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>van den Berg</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Molenaar</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <chapter-title>Myxofibrosarcoma</chapter-title>
          <person-group person-group-type="author">
            <name>
              <surname>Fletcher</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Unni</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <source>WHO classification of tumors - pathology and genetics, tumors of soft
tissue and bone</source>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC Press</publisher-name>
          <year>2002</year>
          <fpage>102</fpage>
          <lpage>1031</lpage>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Elenitsas</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Myxofibrosarcoma in the skin</article-title>
          <source>J Cutan Pathol</source>
          <year>2008</year>
          <volume>35</volume>
          <fpage>935</fpage>
          <lpage>940</lpage>
          <pub-id pub-id-type="pmid">18494817</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mentzel</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Sarcomas of the skin in the elderly</article-title>
          <source>Clin Dermatol</source>
          <year>2011</year>
          <volume>29</volume>
          <fpage>80</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">21146736</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mansoor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>CR</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Myxofibrosarcoma presenting in the skin: clinicopathological
features and differential diagnosis with cutaneous myxoid
neoplasms</article-title>
          <source>Am J Dermatopathol</source>
          <year>2003</year>
          <volume>25</volume>
          <fpage>281</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">12876484</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Fibrous and fibrohistiocytic neoplasms: an update</article-title>
          <source>Dermatol Clin</source>
          <year>2012</year>
          <volume>30</volume>
          <fpage>643</fpage>
          <lpage>656</lpage>
          <comment>vi</comment>
          <pub-id pub-id-type="pmid">23021051</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tupinamb&#xE1;</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Schettini</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>Jd</given-names>
              <suffix>J&#xFA;nior</suffix>
            </name>
            <name>
              <surname>Schettini</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>Fda S</given-names>
            </name>
          </person-group>
          <article-title>Mixofibrossarcoma-case report</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>S110</fpage>
          <lpage>S113</lpage>
          <pub-id pub-id-type="pmid">22068787</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haglund</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Raut</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baldini</surname>
              <given-names>EH</given-names>
            </name>
          </person-group>
          <article-title>Recurrence patterns and survival for patients with intermediate-
and high-grade myxofibrosarcoma</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2012</year>
          <volume>82</volume>
          <fpage>361</fpage>
          <lpage>367</lpage>
          <pub-id pub-id-type="pmid">20951504</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Willems</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Debiec-Rychter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Szuhai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hogendoorn</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Sciot</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Local recurrence of myxofibrosarcoma is associated with increase
in tumour grade and cytogenetic aberrations, suggesting a multistep tumour
progression model</article-title>
          <source>Mod Pathol</source>
          <year>2006</year>
          <volume>19</volume>
          <fpage>407</fpage>
          <lpage>416</lpage>
          <pub-id pub-id-type="pmid">16415793</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
